MTOR and lymphoma: In this study we showed regulation of glucose uptake by c-MYC- and PI3K/AKT/mTOR dependent pathways in lymphoma cell lines and demonstrated evidence for the altered glucose metabolism as a potential target to improve inhibitor-based therapeutic approaches in these cells.